Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.51 is 92% below its 5-year average of -2.87, near the low end of its 5-year range (-5.51–-0.64).
29.34% below its 12-month average of -4.26.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.53.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:57:32.409Z. Historical observations retain their original dates. Historical series through 2025-03-24.
EARNINGS PER SHARE (EPS)
-5.51
EARNINGS PER SHARE (EPS) AVG TTM
-4.26
EARNINGS PER SHARE (EPS) AVG 3Y
-3.91
EARNINGS PER SHARE (EPS) AVG 5Y
-2.87
EARNINGS PER SHARE (EPS) AVG 10Y
-2.45
EARNINGS PER SHARE (EPS) AVG 15Y
-2.16
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.34%
CURRENT VS 3Y AVG
-40.83%
CURRENT VS 5Y AVG
-92.10%
CURRENT VS 10Y AVG
-124.90%
CURRENT VS 15Y AVG
-155.17%
CURRENT VS 20Y AVG
N/A
Neurogene Inc.
Market Cap
$405.53M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.26
3Y Avg
-3.91
5Y Avg
-2.87
Market Cap
$407.71M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$403.34M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$408.05M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
-2.62
5Y Avg
-2.62
Market Cap
$408.21M
Earnings Per Share (EPS)
-4.63
TTM Avg
-6.16
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$408.48M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.86
3Y Avg
-1.02
5Y Avg
-1.51
Market Cap
$411.47M
Earnings Per Share (EPS)
-1.19
TTM Avg
-2.69
3Y Avg
-2.49
5Y Avg
-2.21
Market Cap
$412.21M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
Market Cap
$398.05M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
-1.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | $405.53M | -5.51 | -4.26 | -3.91 | -2.87 |
| Shoulder Innovations, Inc. (SI)vs › | $407.71M | -1.71 | -1.36 | -1.12 | -1.12 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $403.34M | -2.08 | -1.97 | -1.74 | -0.94 |
| Carlsmed, Inc. (CARL)vs › | $408.05M | -1.36 | -1.81 | -2.62 | -2.62 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | -4.63 | -6.16 | -6.16 | -6.16 |
| Rezolute, Inc. (RZLT)vs › | $408.48M | -0.76 | -0.86 | -1.02 | -1.51 |
| Myriad Genetics, Inc. (MYGN)vs › | $411.47M | -1.19 | -2.69 | -2.49 | -2.21 |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.21M | 0.50 | 0.08 | -0.25 | -0.31 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $398.05M | -5.18 | -2.77 | -1.90 | -1.90 |
| Senseonics Holdings, Inc. (SENS)vs › | $413.34M | -2.27 | -2.08 | -0.07 | -5.01 |
Trailing EPS (TTM)
$-5.51
Forward EPS (Est.)
$-5.57
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.24 |
| 2024-12-31 | -4.28 |
| 2023-12-31 | -2.83 |
| 2022-12-31 | -4.30 |
| 2021-12-31 | -0.92 |
| 2020-12-31 | -0.64 |
| 2019-12-31 | -2.57 |
| 2018-12-31 | -1.34 |
| 2017-12-31 | -2.14 |
| 2016-12-31 | -1.96 |
| 2015-12-31 | -1.73 |
| 2014-12-31 | -2.75 |
| 2013-12-31 | -0.87 |
| 2012-12-31 | -0.77 |
| 2011-12-31 | -1.05 |
